Literature DB >> 4308915

Ribonucleic acid synthesis of vesicular stomatitis virus. I. Species of ribonucleic acid found in Chinese hamster ovary cells infected with plaque-forming and defective particles.

M Stampfer, D Baltimore, A S Huang.   

Abstract

Plaque-forming B particles of vesicular stomatitis virus (VSV) induce the synthesis of virus-specific ribonucleic acid (RNA) in Chinese hamster ovary cells, whereas defective T particles do not. Infection with low input multiplicities of B results in the formation of four species of RNA. During infection with high multiplicities, RNA synthesis begins with mainly these four species of RNA but gradually shifts to a new pattern of RNA synthesis involving five other species of RNA. The change can also be induced by superinfection with T at 2.5 hr after infection with a low multiplicity of B. T added at the same time as B prevents virtually all RNA synthesis. Synthesis of the first group of RNA species correlates with the formation of B particles, whereas synthesis of the second group correlates with the formation of T particles. The various species of RNA formed after infection with VSV particles include single-stranded RNA, a completely double-stranded RNA, and RNA with partially double-stranded regions. These observations begin to establish a molecular basis for understanding the ability of T particles to interfere with the growth of B particles.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4308915      PMCID: PMC375850     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  A POSSIBLE MORPHOLOGIC BASIS FOR THE AUTOINTERFERENCE PHENOMENON IN VESICULAR STOMATITIS VIRUS.

Authors:  A J HACKETT
Journal:  Virology       Date:  1964-09       Impact factor: 3.616

2.  BIOLOGIC PROPERTIES OF TWO PLAQUE VARIANTS OF VESICULAR STOMATITIS VIRUS (INDIANA SEROTYPE).

Authors:  R R WAGNER; A H LEVEY; R M SNYDER; G A RATCLIFF; D F HYATT
Journal:  J Immunol       Date:  1963-07       Impact factor: 5.422

3.  POLYRIBOSOMES IN NORMAL AND POLIOVIRUS-INFECTED HELA CELLS AND THEIR RELATIONSHIP TO MESSENGER-RNA.

Authors:  S Penman; K Scherrer; Y Becker; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1963-05       Impact factor: 11.205

4.  The ribonucleic acids of the infective and interfering components of vesicular stomatitis virus.

Authors:  F Brown; S J Martin; B Cartwright; J Crick
Journal:  J Gen Virol       Date:  1967-10       Impact factor: 3.891

5.  An intermediate in the synthesis of poliovirus RNA.

Authors:  D Baltimore; M Girard
Journal:  Proc Natl Acad Sci U S A       Date:  1966-08       Impact factor: 11.205

6.  Comparative sedimentation coefficients of RNA extracted from plaque-forming and defective particles of vesicular stomatitis virus.

Authors:  A S Huang; R R Wagner
Journal:  J Mol Biol       Date:  1966-12-28       Impact factor: 5.469

7.  Inhibition of cellular RNA synthesis by nonreplicating vesicular stomatitis virus.

Authors:  A S Huang; R R Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1965-12       Impact factor: 11.205

8.  The separation of infectious and autointerfering particles in vesicular stomatitis virus preparations.

Authors:  A J Hackett; F L Schaffer; S H Madin
Journal:  Virology       Date:  1967-01       Impact factor: 3.616

9.  Defective T particles of vesicular stomatitis virus. I. Preparation, morphology, and some biologic properties.

Authors:  A S Huang; J W Greenawalt; R R Wagner
Journal:  Virology       Date:  1966-10       Impact factor: 3.616

10.  LIFE CYCLE ANALYSIS OF MAMMALIAN CELLS. II. CELLS FROM THE CHINESE HAMSTER OVARY GROWN IN SUSPENSION CULTURE.

Authors:  T T PUCK; P SANDERS; D PETERSEN
Journal:  Biophys J       Date:  1964-11       Impact factor: 4.033

View more
  73 in total

1.  Epstein-Barr virus-encoded small RNAs (EBERs) do not modulate interferon effects in infected lymphocytes.

Authors:  S Swaminathan; B S Huneycutt; C S Reiss; E Kieff
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  UV inactivation of the biological activity of defective interfering particles generated by vesicular stomatitis virus.

Authors:  P H Bay; M E Reichmann
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

3.  Synthesis of a small RNA in cells coinfected by standard and defective interfering particles of vesicular stomatitis virus.

Authors:  D D Rao; A S Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

4.  Isolation and characterization of a mouse cell line containing a defective Moloney murine leukemia virus genome.

Authors:  P Besmer; H Fan; M Paskind; D Baltimore
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

5.  Envelope proteins and replication of vesicular stomatitis virus: in vivo effects of RNA+ temperature-sensitive mutations on viral RNA synthesis.

Authors:  C Martinet; A Combard; C Printz-Ané; P Printz
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

6.  Molecular analysis of the inhibitory effect of phosphorylated ribavirin on the vesicular stomatitis virus in vitro polymerase reaction.

Authors:  R Fernandez-Larsson; K O'Connell; E Koumans; J L Patterson
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

7.  Dissociation and reconstitution of the transcriptase and template activities of vesicular stomatitis B and T virions.

Authors:  S U Emerson; R R Wagner
Journal:  J Virol       Date:  1972-08       Impact factor: 5.103

8.  Model for vesicular stomatitis virus.

Authors:  B Cartwright; C J Smale; F Brown; R Hull
Journal:  J Virol       Date:  1972-08       Impact factor: 5.103

9.  Transient inhibition of polyoma virus synthesis by sendai virus (parainfluenza I). II. Mechanism of the interference by inactivated virus.

Authors:  G L Smith; R A Consigli
Journal:  J Virol       Date:  1972-12       Impact factor: 5.103

10.  Identification of the vesicular stomatitis virus large protein as a unique viral protein.

Authors:  M Stampfer; D Baltimore
Journal:  J Virol       Date:  1973-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.